Managers / Q1 2023 · view latest →
Prossimo Advisors, LLC
CIK 0001965307 · 1150 OSOS STREET, SUITE 208, SAN LUIS OBISPO, CA, 93401 · 805-548-2800
Summary
Prossimo Advisors, LLC reported $41M in U.S.-listed holdings across 54 positions for Q1 2023.
Its largest position, Shockwave Med, represents 9.9% of the portfolio.
Compared with Q4 2022, the fund opened 4 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 86.6% · $35M
- REIT · 6.3% · $3M
- ETP · 4.8% · $2M
- ADR · 2.3% · $941,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VRTXVERTEX PHARMACEUTICALS INC | NEW | +1.0K | 1.0K | +$323,000 | $323,000 |
| MRNAMODERNA INC | NEW | +1.4K | 1.4K | +$219,000 | $219,000 |
| IRMIRON MTN INC DEL | NEW | +4.1K | 4.1K | +$216,000 | $216,000 |
| GLPIGAMING & LEISURE PPTYS INC | NEW | +4.1K | 4.1K | +$213,000 | $213,000 |
| HYDVANECK ETF TRUST | SOLD OUT | −49.5K | 0 | −$3M | $0 |
| LPLALPL FINL HLDGS INC | SOLD OUT | −3.6K | 0 | −$778,000 | $0 |
| BXBLACKSTONE INC | SOLD OUT | −9.2K | 0 | −$679,000 | $0 |
| CMECME GROUP INC | TRIMMED | −1.3K | 1.2K | −$188,000 | $222,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $16M | 24 | Apr 29, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $16M | 36 | Feb 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $14M | 31 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $125M | 144 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $133M | 134 | May 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $138M | 135 | Jan 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $137M | 140 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $110M | 126 | Jul 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $52M | 60 | May 3, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $47M | 59 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $42M | 56 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $104M | 125 | Jul 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $41M | 54 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $43M | 53 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.